Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.

Josef Priller, Eileen M. Briley, Jaleh Mansouri, William A. Devane, Ken Mackie, Christian C. Felder

Molecular Pharmacology · 1995 · 64 citations · 0 references

Concepts